Radiosensitization, after a combined treatment of survivin siRNA and irradiation, is correlated with the activation of caspases 3 and 7 in a wt-p53 sarcoma cell line, but not in a mt-p53 sarcoma cell line

被引:1
作者
Kappler, M [1 ]
Taubert, H [1 ]
Bartel, F [1 ]
Blümke, K [1 ]
Panian, M [1 ]
Schmidt, H [1 ]
Dunst, J [1 ]
Bache, M [1 ]
机构
[1] Univ Halle Wittenberg, Inst Pathol, Dept Radiotherapy, Fac Med, D-06097 Halle An Der Saale, Germany
关键词
survivin; p53; caspases; small interfering RNA; soft tissue sarcoma; radiosensitivity;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Survivin, a member of the inhibitor-of-apoptosis family is an essential protein for regular mitosis and is involved in an anti-apoptotic pathway. In some studies, an association between survivin expression and radiosensitivity has been described for tumor cells, but the relationship between p53 and survivin regarding radioresistance remains to be clarified. In order to increase the effect of irradiation on two sarcoma cell lines, A-204 with wt-p53 and US 8-93 with mt-p53, siRNA was applied to knock down survivin expression. The effects of combined treatment of siRNA treatment and irradiation were investigated by clonogenic survival assay, measurement of activity of caspases 3 and 7, Western blot hybridization for survivin and p53, and morphological analysis of apoptosis. Survivin knock down caused radiosensitization in the cell line A-204 (wt-p53) with an enhancement factor of 1.8 at 2 Gy (p=0.05) and 2.5 at 4 Gy (p=0.02), respectively. No radiosensitization was found in the cell line US 8-93 (mt-p53), when clonogenic survival was analyzed. These findings were supported by an increase in activity (up to 5.2-fold) of caspases 3 and 7 in cell line A204 (wt-p53), but not in cell line US 8-93 (mt-p53) after a combined treatment of siRNA and irradiation. Our findings suggest that the wt-p53-caspase pathway is of importance for the radiosensitization induced by targeting survivin, which may have an impact on future gene therapeutical treatments.
引用
收藏
页码:167 / 172
页数:6
相关论文
共 36 条
[1]   Validating survivin as a cancer therapeutic target [J].
Altieri, DC .
NATURE REVIEWS CANCER, 2003, 3 (01) :46-54
[2]   A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma [J].
Ambrosini, G ;
Adida, C ;
Altieri, DC .
NATURE MEDICINE, 1997, 3 (08) :917-921
[3]   Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting [J].
Ambrosini, G ;
Adida, C ;
Sirugo, G ;
Altieri, DC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (18) :11177-11182
[4]   Survivin as a radioresistance factor in pancreatic cancer [J].
Asanuma, K ;
Moriai, R ;
Yajima, T ;
Yagihashi, A ;
Yamada, M ;
Kobayashi, D ;
Watanabe, N .
JAPANESE JOURNAL OF CANCER RESEARCH, 2000, 91 (11) :1204-1209
[5]   A role for survivin in radioresistance of pancreatic cancer cells [J].
Asanuma, K ;
Kobayashi, D ;
Furuya, D ;
Tsuji, N ;
Yagihashi, A ;
Watanabe, N .
JAPANESE JOURNAL OF CANCER RESEARCH, 2002, 93 (09) :1057-1062
[6]  
Bache M, 1999, ANTICANCER RES, V19, P1827
[7]  
Bache M, 1997, INT J ONCOL, V11, P993
[8]   Survivin does not inhibit caspase-3 activity [J].
Banks, DP ;
Plescia, J ;
Altieri, DC ;
Chen, J ;
Rosenberg, SH ;
Zhang, HC ;
Ng, SC .
BLOOD, 2000, 96 (12) :4002-4002
[9]   Acute ablation of survivin uncovers p53-dependent mitotic checkpoint functions and control of mitochondrial apoptosis [J].
Beltrami, E ;
Plescia, J ;
Wilkinson, JC ;
Duckett, CS ;
Altieri, DC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (03) :2077-2084
[10]  
Blanc-Brude OP, 2003, CLIN CANCER RES, V9, P2683